GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Nielsen, Jonas B
Schultheiss, Ulla T
Fritsche, Lars G
Graham, Sarah E
Wolford, Brooke N
Haug, Eirin B
Gabrielsen, Maiken E
Skogholt, Anne Heidi
Davey Smith, George
Hornsby, Whitney E
Jonasson, Jon G
Ringel, Matthew D
Kiemeney, Lambertus A
Netea-Maier, Romana T
Mayordomo, Jose I
Plantinga, Theo S
Sturgis, Erich M
Citterio, Cintia E
Brummett, Chad M
de la Chapelle, Albert
Willer, Cristen J
Åsvold, Bjørn Olav
MetadataShow full item record
CitationZhou W, Brumpton B, Kabil O, et al. GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer. Nat Commun. 2020;11(1):3981. Published 2020 Aug 7. doi:10.1038/s41467-020-17718-z
AbstractThyroid stimulating hormone (TSH) is critical for normal development and metabolism. To better understand the genetic contribution to TSH levels, we conduct a GWAS meta-analysis at 22.4 million genetic markers in up to 119,715 individuals and identify 74 genome-wide significant loci for TSH, of which 28 are previously unreported. Functional experiments show that the thyroglobulin protein-altering variants P118L and G67S impact thyroglobulin secretion. Phenome-wide association analysis in the UK Biobank demonstrates the pleiotropic effects of TSH-associated variants and a polygenic score for higher TSH levels is associated with a reduced risk of thyroid cancer in the UK Biobank and three other independent studies. Two-sample Mendelian randomization using TSH index variants as instrumental variables suggests a protective effect of higher TSH levels (indicating lower thyroid function) on risk of thyroid cancer and goiter. Our findings highlight the pleiotropic effects of TSH-associated variants on thyroid function and growth of malignant and benign thyroid tumors.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download
- Thyroid Stimulating Hormone and Bone Mineral Density: Evidence From a Two-Sample Mendelian Randomization Study and a Candidate Gene Association Study.
- Authors: van Vliet NA, Noordam R, van Klinken JB, Westendorp RG, Bassett JD, Williams GR, van Heemst D
- Issue date: 2018 Jul
- Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two-sample Mendelian randomization study.
- Authors: Yuan S, Kar S, Vithayathil M, Carter P, Mason AM, Burgess S, Larsson SC
- Issue date: 2020 Oct 1
- A genome-wide association study of thyroid stimulating hormone and free thyroxine in Danish children and adolescents.
- Authors: Nielsen TR, Appel EV, Svendstrup M, Ohrt JD, Dahl M, Fonvig CE, Hollensted M, Have CT, Kadarmideen HN, Pedersen O, Hansen T, Holm JC, Grarup N
- Issue date: 2017
- Phenome-wide functional dissection of pleiotropic effects highlights key molecular pathways for human complex traits.
- Authors: Shikov AE, Skitchenko RK, Predeus AV, Barbitoff YA
- Issue date: 2020 Jan 23
- Pleiotropic effects of thyroid stimulating hormone in a differentiated thyroid cancer cell line. Studies on proliferation, thyroglobulin secretion, adhesion, migration and invasion.
- Authors: Zielke A, Hoffmann S, Plaul U, Duh QY, Clark OH, Rothmund M
- Issue date: 1999